CUSIP 61225M102COMGLUEQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
159 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Nea Management Company, LLC | 7.69M | $120.62M | 0 | Held |
| 2 | Tcg Crossover Management, LLC | 4.62M | $72.48M | +4.62M | New |
| 3 | Versant Venture Management, LLC | 4.38M | $68.72M | −1.27M | Reduced |
| 4 | Baker Bros. Advisors LP | 4.35M | $68.14M |
| −570.4K |
| Reduced |
| 5 | Blackrock, Inc. | 4.18M | $65.56M | +366.0K | Added |
| 6 | Bvf Inc/Il | 3.84M | $60.15M | −1.82M | Reduced |
| 7 | Suvretta Capital Management, LLC | 3.36M | $52.68M | 0 | Held |
| 8 | Vanguard Group Inc | 3.25M | $50.91M | +257.5K | Added |
| 9 | State Street Corp | 2.11M | $33.05M | +1.26M | Added |
| 10 | Aisling Capital Management LP | 1.47M | $23.09M | 0 | Held |
See every fund holding Monte Rosa Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders